J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer

Gainor, JF; Shaw, AT

Gainor, JF (reprint author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.

LANCET, 2017; 390 (10089): 3